A drug utilization study to evaluate the prescribing pattern of clotrimazole dusting powder in dermatophytosis

Authors

  • Deepak Jakhar Dermosphere Clinic, New Delhi, India
  • Pallavi Mishra Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd., Mumbai, India
  • Dhiraj Dhoot Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd., Mumbai, India
  • Saiprasad Patil Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd., Mumbai, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20260382

Keywords:

Drug utilization, WHO, Clotrimazole

Abstract

The drug utilization studies are essential tools for the monitoring various healthcare system. According to the world health organization (WHO), a drug utilization study is "the marketing, distribution, prescription, and drug usage in a society, leading to medical, social, and economic consequences".

Metrics

Metrics Loading ...

References

Bakassas I, lunde PKM. National drug policies: the need for drug utilization studies. Trends Pharmacol Sci. 1986;7:331-4. DOI: https://doi.org/10.1016/0165-6147(86)90375-5

WHO policy perspectives in medicines. Promoting rational use of medicines: World Health Organization. 2002. Available at: http://www/who.int/medicines/publications/policyper spectives/ppm05en.pdf. Accessed on 14 January 2026.

Sardana K, Khurana A. Overview of topical antifungal formulations in superficial fungal infections. Indian J Dermatol. 2017;62(3):264-71.

Dogra S, Uprety S. The menace of steroid-modified tinea: the urgent need for antifungal stewardship. Indian Dermatol Online J. 2020;11(4):527-8.

Ongsri P, Bunyaratavej S, Leeyaphan C, Pattanaprichakul P, Ongmahutmongkol P, Ariyatanasuporn N, et al. Efficacy of antifungal cream versus powder in the treatment of fungal foot skin infection and unpleasant foot odor at medical department of thai naval rating school. Southeast Asian J Trop Med Publ Heal. 2018;49(2):297-303.

Ongsri P, Bangchang NN, Saengthong-Aram P, Leeyaphan C, Pattanaprichakul P, Bunyaratavej S. Efficacy of 1% Clotrimazole Powder Monotherapy for Treating Tinea Cruris: A Comparative Randomized Study. Mil Med. 2024;189(11-12):e2494-8. DOI: https://doi.org/10.1093/milmed/usae105

Desomchoke R, Bunyaratavej S, Leeyaphan C. Efficacy and safety of 1% clotrimazole powder, adjuvant therapy in patients with superficial fungal cutaneous infection in intertriginous areas. J Med Assoc Thai. 2016;99(12):1355-9.

Jagia R, Mishra P, Dhoot D. Clotrimazole Dusting Powder Improves Patient-Reported Outcomes in Patients with Dermatophytosis: Real World Analysis from India. J Dermatol Res. 2026;7(1):1-3. DOI: https://doi.org/10.46889/JDR.2026.7110

Downloads

Published

2026-02-20

How to Cite

Jakhar, D., Mishra, P., Dhoot, D., & Patil, S. (2026). A drug utilization study to evaluate the prescribing pattern of clotrimazole dusting powder in dermatophytosis. International Journal of Research in Dermatology, 12(2), 193–194. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20260382

Issue

Section

Letter to the Editor